Filing Details

Accession Number:
0001140361-11-029325
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-23 16:43:59
Reporting Period:
2011-05-19
Filing Date:
2011-05-23
Accepted Time:
2011-05-23 16:43:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1010086 Siga Technologies Inc SIGA Pharmaceutical Preparations (2834) 133864870
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301548 E Dennis Hruby C/O Siga Technologies, Inc.
35 East 62Nd Street
New York NY 10065
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Acquisiton 2011-05-19 300,000 $2.50 425,000 No 4 M Direct
Common Stock, Par Value $.0001 Per Share Disposition 2011-05-19 41,300 $13.64 383,700 No 4 S Direct
Common Stock, Par Value $.0001 Per Share Disposition 2011-05-20 188,000 $13.51 195,700 No 4 S Direct
Common Stock, Par Value $.0001 Per Share Disposition 2011-05-23 70,700 $13.09 125,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $.0001 Per Share Stock Option (Right to buy) Disposition 2011-05-19 300,000 $0.00 300,000 $2.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-07-23 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $13.79, inclusive. The reporting person undertakes to provide to SIGA Technologies, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.26 to $13.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. The option vested in equal yearly installments over a period of three (3) years, with the first 1/3 of such option vesting on July 23, 2003, the second 1/3 of such option vesting on July 23, 2004 and the remaining 1/3 of such option vesting on July 23, 2005.